| 摘要 |
PCT No. PCT/AU91/00309 Sec. 371 Date Feb. 10, 1993 Sec. 102(e) Date Feb. 10, 1993 PCT Filed Jul. 10, 1991 PCT Pub. No. WO92/00754 PCT Pub. Date Jan. 23, 1992.Fetal growth is promoted and fetal growth retardation is reduced in mammals by increasing in a maternal host during pregnancy the active concentration of IGF-1 and /or IGF-2 and/or analogues thereof. The active concentration of IGF-1 and/or IGF-2 and/or analogues thereof may be increased either by directly administering to the maternal host IGF-1 and/or IGF-2 and/or analogs thereof or by administering another compound which, upon being so administered, causes an increase in the active concentration of IGF-1 and/or IGF-2 and/or analogues thereof in the maternal host. |
